← Back to Search

Prebiotic

Camu camu for Obesity

N/A
Waitlist Available
Research Sponsored by Laval University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up change between the beginning and the end of each treatment (12 weeks each)
Awards & highlights

Study Summary

This trial will test the hypothesis that 4 weeks of oral intake of CC can modulate the gut microbiota and protect against obesity and associated metabolic disorders in humans.

Eligible Conditions
  • Obesity
  • Non-alcoholic Fatty Liver Disease
  • Metabolic Syndrome
  • Insulin Resistance
  • Microtia
  • Endotoxemia

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~change between the beginning and the end of each treatment (12 weeks each)
This trial's timeline: 3 weeks for screening, Varies for treatment, and change between the beginning and the end of each treatment (12 weeks each) for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change in Gut Microbiota Composition and Diversity
Change in fat accumulation in the liver
Secondary outcome measures
Change in Endotoxemia
Change in Glucose homeostasis
Change in Inflammation state of the tissue
+13 more

Trial Design

2Treatment groups
Experimental Treatment
Placebo Group
Group I: Camu camuExperimental Treatment1 Intervention
Group II: PlaceboPlacebo Group1 Intervention
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Camu camu
2020
N/A
~40

Find a Location

Who is running the clinical trial?

Laval UniversityLead Sponsor
417 Previous Clinical Trials
172,237 Total Patients Enrolled
33 Trials studying Obesity
16,292 Patients Enrolled for Obesity

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
clinicaltrials.govStudy
Demonstration of the Prebiotic-like Effects of Camu-camu Consumption Against Obesity-related Disorders in Humans
André Marette 2020. "Demonstration of the Prebiotic-like Effects of Camu-camu Consumption Against Obesity-related Disorders in Humans". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT04130321.
~8 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top